EyeGate Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2021 | 237,477 | $534,000 | 1,502.08% | 3.36% |
| VANGUARD GROUP INC | 11/12/2021 | 151,702 | $341,000 | 18.73% | 2.15% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/15/2021 | 51,300 | $115,000 | 100.00% | 0.73% |
| JANE STREET GROUP, LLC | 11/16/2021 | 34,742 | $78,000 | 100.00% | 0.49% |
| SASSICAIA CAPITAL ADVISERS LLC | 11/15/2021 | 25,000 | $56,000 | 100.00% | 0.35% |
| BLACKROCK INC. | 11/09/2021 | 20,981 | $47,000 | 0.00% | 0.30% |
| TUTTLE CAPITAL MANAGEMENT, LLC | 10/22/2021 | 18,174 | $41,000 | 100.00% | 0.26% |
| XTX TOPCO LTD | 11/12/2021 | 13,867 | $31,000 | 100.00% | 0.20% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/15/2021 | 13,832 | $31,000 | 100.00% | 0.20% |
| CREDIT SUISSE AG/ | 11/12/2021 | 10,250 | $23,000 | 100.00% | 0.15% |
| HRT FINANCIAL LP | 11/15/2021 | 10,023 | $22,000 | 100.00% | 0.14% |
| US BANCORP \DE\ | 11/10/2021 | 2,710 | $6,000 | 0.00% | 0.04% |
| ROYAL BANK OF CANADA | 11/15/2021 | 1,690 | $4,000 | 0.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 11/05/2021 | 1,468 | $3,000 | 213.68% | 0.02% |
| STERLING FINANCIAL PLANNING, INC. | 10/28/2021 | 1,171 | $3,000 | 0.00% | 0.02% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 10/27/2021 | 1,000 | $2,000 | 0.00% | 0.01% |
| MORGAN STANLEY | 11/15/2021 | 466 | $1,000 | 0.00% | 0.01% |
| UBS GROUP AG | 11/15/2021 | 399 | $1,000 | 0.00% | 0.01% |
| ALBION FINANCIAL GROUP /UT | 10/19/2021 | 254 | $1,000 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/15/2021 | 77 | $0 | 92.50% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 11/09/2021 | 0 | $0 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 11/15/2021 | 0 | $0 | -100.00% | 0.00% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/12/2021 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
EyeGate Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of EyeGate Pharmaceuticals, Inc.. The most heavily invested institutionals were:
LADENBURG THALMANN FINANCIAL SERVICES INC.: 614
8.45% of EyeGate Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 614 shares in the last 24 months. This purchase volume represents approximately $21,410 in transactions.